LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 18 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,117,000 | -0.2% | 2,800,000 | 0.0% | 0.17% | -4.9% |
| Q3 2017 | $5,126,000 | -35.6% | 2,800,000 | -41.7% | 0.18% | -38.9% |
| Q2 2017 | $7,962,000 | +11.2% | 4,800,000 | 0.0% | 0.30% | +8.8% |
| Q1 2017 | $7,160,000 | +3.0% | 4,800,000 | 0.0% | 0.27% | +5.0% |
| Q4 2016 | $6,952,000 | -1.1% | 4,800,000 | 0.0% | 0.26% | +4.4% |
| Q3 2016 | $7,027,000 | -12.3% | 4,800,000 | 0.0% | 0.25% | -14.1% |
| Q2 2016 | $8,014,000 | +9.5% | 4,800,000 | 0.0% | 0.29% | +21.8% |
| Q1 2016 | $7,316,000 | -1.7% | 4,800,000 | 0.0% | 0.24% | -1.2% |
| Q4 2015 | $7,440,000 | -28.1% | 4,800,000 | -40.0% | 0.24% | -20.7% |
| Q3 2015 | $10,350,000 | – | 8,000,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 57,915,000 | $89,697,000 | 5.40% |
| Man Investments (CH) AG | 4,000,000 | $6,224,000 | 2.47% |
| CAMDEN ASSET MANAGEMENT L P /CA | 38,150,000 | $58,846,000 | 1.85% |
| BASSO CAPITAL MANAGEMENT, L.P. | 7,720,000 | $11,947,000 | 1.77% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $37,808,000 | 0.81% |
| CSS LLC/IL | 4,000,000 | $6,192,000 | 0.37% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $7,440,000 | 0.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3,922,000 | $6,193,000 | 0.10% |
| Calamos Advisors LLC | 7,000,000 | $10,893,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 17,200,000 | $26,617,000 | 0.06% |